BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32024620)

  • 1. Screening of phytochemicals against Keap1- NRF2 interaction to reactivate NRF2 Functioning: Pharmacoinformatics based approach.
    Akmal A; Javaid A; Hussain R; Kanwal A; Zubair M; Ashfaq UA
    Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2823-2828. PubMed ID: 32024620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Keap1-Nrf2 small-molecule inhibitors from phytochemicals based on molecular docking.
    Li M; Huang W; Jie F; Wang M; Zhong Y; Chen Q; Lu B
    Food Chem Toxicol; 2019 Nov; 133():110758. PubMed ID: 31412289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model.
    Kim S; Indu Viswanath AN; Park JH; Lee HE; Park AY; Choi JW; Kim HJ; Londhe AM; Jang BK; Lee J; Hwang H; Lim SM; Pae AN; Park KD
    Neuropharmacology; 2020 May; 167():107989. PubMed ID: 32032607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases.
    Cuadrado A; Rojo AI; Wells G; Hayes JD; Cousin SP; Rumsey WL; Attucks OC; Franklin S; Levonen AL; Kensler TW; Dinkova-Kostova AT
    Nat Rev Drug Discov; 2019 Apr; 18(4):295-317. PubMed ID: 30610225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel diterpenoid-type activators of the Keap1/Nrf2/ARE signaling pathway and their regulation of redox homeostasis.
    Li AL; Shen T; Wang T; Zhou MX; Wang B; Song JT; Zhang PL; Wang XL; Ren DM; Lou HX; Wang XN
    Free Radic Biol Med; 2019 Sep; 141():21-33. PubMed ID: 31167117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1).
    Bresciani A; Missineo A; Gallo M; Cerretani M; Fezzardi P; Tomei L; Cicero DO; Altamura S; Santoprete A; Ingenito R; Bianchi E; Pacifici R; Dominguez C; Munoz-Sanjuan I; Harper S; Toledo-Sherman L; Park LC
    Arch Biochem Biophys; 2017 Oct; 631():31-41. PubMed ID: 28801166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.
    Suzuki T; Yamamoto M
    J Biol Chem; 2017 Oct; 292(41):16817-16824. PubMed ID: 28842501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex.
    Bello M; Morales-González JA
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):981-992. PubMed ID: 28746889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism.
    Song MY; Lee DY; Chun KS; Kim EH
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pterostilbene-mediated Nrf2 activation: Mechanistic insights on Keap1:Nrf2 interface.
    Bhakkiyalakshmi E; Dineshkumar K; Karthik S; Sireesh D; Hopper W; Paulmurugan R; Ramkumar KM
    Bioorg Med Chem; 2016 Aug; 24(16):3378-86. PubMed ID: 27312421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation Spectroscopy.
    Yoshizaki Y; Mori T; Ishigami-Yuasa M; Kikuchi E; Takahashi D; Zeniya M; Nomura N; Mori Y; Araki Y; Ando F; Mandai S; Kasagi Y; Arai Y; Sasaki E; Yoshida S; Kagechika H; Rai T; Uchida S; Sohara E
    Sci Rep; 2017 Jun; 7(1):3945. PubMed ID: 28638054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
    Davies TG; Wixted WE; Coyle JE; Griffiths-Jones C; Hearn K; McMenamin R; Norton D; Rich SJ; Richardson C; Saxty G; Willems HM; Woolford AJ; Cottom JE; Kou JP; Yonchuk JG; Feldser HG; Sanchez Y; Foley JP; Bolognese BJ; Logan G; Podolin PL; Yan H; Callahan JF; Heightman TD; Kerns JK
    J Med Chem; 2016 Apr; 59(8):3991-4006. PubMed ID: 27031670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Screening Approaches in the Development of Nrf2-Keap1 Protein-Protein Interaction Inhibitors.
    Leung CH; Zhang JT; Yang GJ; Liu H; Han QB; Ma DL
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31509940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc-binding triggers a conformational-switch in the cullin-3 substrate adaptor protein KEAP1 that controls transcription factor NRF2.
    McMahon M; Swift SR; Hayes JD
    Toxicol Appl Pharmacol; 2018 Dec; 360():45-57. PubMed ID: 30261176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity.
    Lu MC; Zhang X; Wu F; Tan SJ; Zhao J; You QD; Jiang ZY
    J Med Chem; 2019 Jul; 62(14):6796-6813. PubMed ID: 31283229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shinorine ameliorates chromium induced toxicity in zebrafish hepatocytes through the facultative activation of Nrf2-Keap1-ARE pathway.
    Shaw P; Sen A; Mondal P; Dey Bhowmik A; Rath J; Chattopadhyay A
    Aquat Toxicol; 2020 Nov; 228():105622. PubMed ID: 32947073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-κB activation.
    Lu MC; Zhao J; Liu YT; Liu T; Tao MM; You QD; Jiang ZY
    Redox Biol; 2019 Sep; 26():101266. PubMed ID: 31279986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of novel small-molecule NRF2 activators: Structural and biochemical validation of stereospecific KEAP1 binding.
    Huerta C; Jiang X; Trevino I; Bender CF; Ferguson DA; Probst B; Swinger KK; Stoll VS; Thomas PJ; Dulubova I; Visnick M; Wigley WC
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2537-2552. PubMed ID: 27474998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells.
    Panieri E; Saso L
    Antioxid Redox Signal; 2021 Jun; 34(18):1428-1483. PubMed ID: 33403898
    [No Abstract]   [Full Text] [Related]  

  • 20. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
    Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.